{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:37:15Z","timestamp":1790743035355,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.dsx.2016.08.026","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T11:55:53Z","timestamp":1472039753000},"page":"179-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Homocysteine is a marker for metabolic syndrome and atherosclerosis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-9848","authenticated-orcid":false,"given":"Branko","family":"Sreckovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna Dimitrijevic","family":"Sreckovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Soldatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Sumarac-Dumanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristina","family":"Janeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Janeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Gacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Mrdovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2016.08.026_bib0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2016.08.026_bib0010","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflamation in fat plays a crucial role in the development of obesity-related insulin resistence","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dsx.2016.08.026_bib0015","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dsx.2016.08.026_bib0020","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"ExpertPanelonDetaction Evaluation s. treatment of High Blood Cholesterol in Adult","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.dsx.2016.08.026_bib0025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1515\/CCLM.2007.259","article-title":"Prothrombogenic factors and reduced antioxidative deffence in the cildren and adolescents with pre-methaboloc and metabolic syndrome","volume":"45","author":"Dimitrijevi\u0107 Sre\u0107kovi\u0107","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dsx.2016.08.026_bib0030","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.026_bib0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Blood I: Definition of metabolic syndrome: report of the National Heart Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2016.08.026_bib0040","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Clarke","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2016.08.026_bib0045","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","article-title":"Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study","volume":"24","author":"Meigs","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.026_bib0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/hrt.2006.093971","article-title":"Group SS: levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome","volume":"93","author":"Hajer","year":"2007","journal-title":"Heart"},{"issue":"August (7)","key":"10.1016\/j.dsx.2016.08.026_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5830\/CVJA-2013-059","article-title":"Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity","volume":"24","author":"Sengwayo","year":"2013","journal-title":"Cardiovasc J Afr"},{"issue":"5","key":"10.1016\/j.dsx.2016.08.026_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jjcc.2014.11.010","article-title":"Biochemical view on Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease","volume":"65","author":"Sertoglu","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.dsx.2016.08.026_bib0065","series-title":"Odredjivanje nivoa homocysteinea kao nezavisnog faktora rizika za koronarnu bolest Rad iz u\u017ee specijalizacije","author":"Sre\u0107kovi\u0107","year":"2010"},{"key":"10.1016\/j.dsx.2016.08.026_bib0070","article-title":"Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients","volume":"12","author":"Catena","year":"2014","journal-title":"Am J Hypertens Dec"},{"issue":"April (4)","key":"10.1016\/j.dsx.2016.08.026_bib0075","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/nu6041649","article-title":"High plasma homocysteine increases risk of metabolic syndrome in 6\u20138year old children in rural Nepal","volume":"6","author":"Yakub","year":"2014","journal-title":"Nutrients"},{"issue":"May","key":"10.1016\/j.dsx.2016.08.026_bib0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1758-5996-6-62","article-title":"Epicardial adipose tissue thickness and plasma homocysteine in patients with metabolic syndrome and normal coronary arteries","volume":"6","author":"Balcio\u011flu","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.dsx.2016.08.026_bib0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.maturitas.2003.12.009","article-title":"Venous and arterial thrombosis: epidemiology and risk factors at various ages","volume":"47","author":"Lowe","year":"2004","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.dsx.2016.08.026_bib0090","first-page":"21","article-title":"Serum homocysteine concentrations in patients with hypertension","volume":"4","author":"Atif","year":"2008","journal-title":"Pak J Physiol"},{"key":"10.1016\/j.dsx.2016.08.026_bib0095","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.HYP.0000101690.58391.13","article-title":"Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham heart study","volume":"42","author":"Sundstr\u00f6m","year":"2003","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.dsx.2016.08.026_bib0100","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1161\/STROKEAHA.109.551416","article-title":"Homocysteine and cholesterol: guilt by association?","volume":"40","author":"Obeid","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.dsx.2016.08.026_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/CH-2010-1366","article-title":"Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study","volume":"47","author":"Vay\u00e1","year":"2011","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"10.1016\/j.dsx.2016.08.026_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2006.07.026","article-title":"Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats","volume":"76","author":"Golbahar","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.dsx.2016.08.026_bib0115","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/ajcn\/85.6.1598","article-title":"Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study","volume":"85","author":"Berstad","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.dsx.2016.08.026_bib0120","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1182\/blood-2002-08-2606","article-title":"Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E doubleknock-out mice with and without dietary perturbation","volume":"101","author":"Wang","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.dsx.2016.08.026_bib0125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","article-title":"Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways","volume":"107","author":"Werstuck","year":"2001","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.dsx.2016.08.026_bib0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.febslet.2009.03.038","article-title":"Homocysteine and lipids: s-adenosyl methionine as a key intermediate","volume":"583","author":"Obeid","year":"2009","journal-title":"FEBS Lett"},{"issue":"13","key":"10.1016\/j.dsx.2016.08.026_bib0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.dsx.2016.08.026_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(97)00090-7","article-title":"Stimulation of endothelial nitric oxide production by homocyst(e)ine","volume":"132","author":"Upchurch","year":"1997","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.dsx.2016.08.026_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.dsx.2016.08.026_bib0150","doi-asserted-by":"crossref","first-page":"E703","DOI":"10.1152\/ajpendo.00050.2011","article-title":"Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway","volume":"301","author":"Wang","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2016.08.026_bib0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00394-015-0831-3","article-title":"Effects of total fibre or resistant starch-rich diets within lifestyle intervention in obese prediabetic adults","volume":"55","author":"Dodevska","year":"2016","journal-title":"Eur J Nutr"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116302004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116302004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T09:46:10Z","timestamp":1601027170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402116302004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1871402116302004"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2016.08.026","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine is a marker for metabolic syndrome and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2016.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}